【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 8-K Current report, item 5.07 Accession Number: 0001193125-23-156565 Act: 34 Size: 154 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-012301 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 144 Report of proposed sale of securities Accession Number: 0001949846-23-000098 Act: 33 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-009884 Act: 34 Size: 7 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-23-008662 Act: 34 Size: 149 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-23-008665 Act: 34 Size: 480 KB 网页链接
$Neuronetics(STIM)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-23-018218 Act: 34 Size: 1 MB 网页链接
$Neuronetics(STIM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-23-018219 Act: 34 Size: 3 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 1.01, 2.03, 7.01, and 9.01 Accession Number: 0001193125-23-090435 Act: 34 Size: 1 MB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001058854-23-000017 Size: 8 KB 网页链接